[Federal Register: September 25, 2009 (Volume 74, Number 185)]
[Notices]
[Page 48992-48993]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr25se09-99]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3216-N]
Medicare Program; Request for Nominations for Members for the
Medicare Evidence Development & Coverage Advisory Committee
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the request for nominations for
consideration for membership on the Medicare Evidence Development &
Coverage Advisory Committee (MEDCAC). Among other things, the MEDCAC
advises the Secretary of the Department of Health and Human Services
(the Secretary) and the Administrator of the Centers for Medicare &
Medicaid Services, as requested by the Secretary, whether medical items
and services are ``reasonable and necessary'' and therefore eligible
for coverage under Title XVIII of the Social Security Act.
We are requesting nominations for both voting and nonvoting members
to serve on the MEDCAC. Nominees are selected based upon their
individual qualifications and not as representatives of professional
associations or societies. We have a special interest in ensuring that
women, minority groups, and physically challenged individuals are
adequately represented on the MEDCAC. Therefore, we encourage
nominations of qualified candidates from these groups.
The MEDCAC reviews and evaluates medical literature, reviews
technology assessments, and examines data and information on the
effectiveness and appropriateness of medical items and services that
are covered or eligible for coverage under Medicare.
DATES: Nominations will be considered if postmarked by Monday, October
26, 2009 and mailed to the address specified in the ADDRESSES section
of this notice.
ADDRESSES: You may mail nominations for membership to the following
address: Centers for Medicare & Medicaid Services, Office of Clinical
Standards and Quality, Attention: Maria Ellis, 7500 Security Boulevard,
Mail Stop: Central Building 1-09-06, Baltimore, MD 21244.
FOR FURTHER INFORMATION CONTACT: Maria Ellis, Executive Secretary for
MEDCAC, Centers for Medicare & Medicaid Services, Office of Clinical
Standards and Quality, Coverage and Analysis Group, C1-09-06, 7500
Security Boulevard, Baltimore, MD 21244 or contact Ms. Ellis by phone
(410-786-0309) or via e-mail at Maria.Ellis@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
On December 14, 1998, we published a notice in the Federal Register
(63 FR 68780) announcing establishment of the Medicare Coverage
Advisory Committee (MCAC). The Secretary signed the initial charter for
the Medicare Coverage Advisory Committee on November 24, 1998. On
January 26, 2007 the Secretary published a notice in the Federal
Register (72 FR 3853), changing the Committee's name to the Medicare
Evidence Development and Coverage Advisory Committee (MEDCAC). The
charter for the committee was renewed by the Secretary and will
terminate on November 24, 2010, unless renewed again by the Secretary.
The MEDCAC is governed by provisions of the Federal Advisory
Committee Act, Public Law 92-463, as amended (5 U.S.C. App. 2), which
sets forth standards for the formulation and use of advisory
committees, and is authorized by section 222 of the Public Health
Service Act as amended (42 U.S.C. 217A).
The MEDCAC consists of a pool of 100 appointed members including: 6
patient advocates, who are standard voting members, and 6
representatives of industry interests, who are nonvoting members.
Members are selected from among authorities in clinical medicine of all
specialties, administrative medicine, public health, biologic and
physical sciences, health care data and information management and
analysis, patient advocacy, the economics of health care, medical
ethics, and other related professions such as epidemiology and
biostatistics, and methodology of trial design.
The MEDCAC functions on a committee basis. The committee reviews
and evaluates medical literature, reviews technology assessments, and
examines data and information on the effectiveness and appropriateness
of medical items and services that are covered or eligible for coverage
under Medicare. The Committee works from an agenda provided by the
Designated Federal Official that lists specific issues, and develops
technical advice to assist us in determining reasonable and necessary
applications of medical services and technology when we make national
coverage decisions for Medicare. The Committee also advises CMS as part
of Medicare's coverage evidence development activities.
II. Provisions of the Notice
As of December 2009, there will be 45 terms of membership expiring,
3 of which are nonvoting industry representatives.
Accordingly, we are requesting nominations for both voting and
nonvoting members to serve on the MEDCAC. Nominees are selected based
upon their individual qualifications and not as representatives of
professional associations or societies. We have a special interest in
ensuring that women,
[[Page 48993]]
minority groups, and physically challenged individuals are adequately
represented on the MEDCAC. Therefore, we encourage nominations of
qualified candidates from these groups.
All nominations must be accompanied by curricula vitae. Nomination
packages must be sent to Maria Ellis at the address listed in the
ADDRESSES section of this notice. Nominees for voting membership must
also have expertise and experience in one or more of the following
fields:
Clinical medicine of all specialties.
Administrative medicine.
Public health.
Patient advocacy.
Biologic and physical sciences.
Health care data and information management and analysis.
The economics of health care.
Medical ethics.
Other related professions such as epidemiology and
biostatistics, and methodology of clinical trial design.
We are looking for experts in a number of fields. Our most critical
needs are for experts in hematology; genomics; end of life care;
Bayesian statistics; clinical epidemiology; clinical trial methodology;
knee, hip, and other joint replacement surgery; ophthalmology;
psychopharmacology; registries; rheumatology; screening and diagnostic
testing analysis; and stroke. We also need experts in biostatistics in
clinical settings, cardiovascular epidemiology, cost effectiveness
analysis, dementia, endocrinology, geriatrics, gynecology, minority
health, observational research design, stroke, epidemiology, and
women's health.
The nomination letter must include a statement that the nominee is
willing to serve as a member of the MEDCAC and appears to have no
conflict of interest that would preclude membership. We are requesting
that all curricula vitae include the following:
Date of birth.
Place of birth.
Social security number.
Title and current position.
Professional affiliation.
Home and business address.
Telephone and fax numbers.
E-mail address.
List of areas of expertise.
In the nominations letter, we are requesting that the nominee specify
whether applying for a Voting position or Industry Representative.
Potential candidates will be asked to provide detailed information
concerning such matters as financial holdings, consultancies, and
research grants or contracts in order to permit evaluation of possible
sources of conflict of interest.
Members are invited to serve for overlapping 2-year terms. A member
may serve after the expiration of the member's term until a successor
takes office. Any interested person may nominate one or more qualified
persons. Self-nominations are also accepted.
The current Secretary's Charter for the MEDCAC is available on the
CMS Web site at: http://www.cms.hhs.gov/FACA/Downloads/
medcaccharter.pdf, or you may obtain a copy of the charter by
submitting a request to the contact listed in the FOR FURTHER
INFORMATION section of this notice.
Authority: 5 U.S.C. App. 2, section 10(a)(1) and (a)(2).
(Catalog of Federal Domestic Assistance Program No. 93.773,
Medicare--Hospital Insurance; and Program No. 93.774, Medicare--
Supplementary Medical Insurance Program)
Dated: September 21, 2009.
Barry M. Straube,
CMS Chief Medical Officer, Director, Office of Clinical Standards and
Quality, Centers for Medicare & Medicaid Services.
[FR Doc. E9-23257 Filed 9-24-09; 8:45 am]
BILLING CODE 4120-01-P